Ahmad Nakshabandi
Overview
Explore the profile of Ahmad Nakshabandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Woo S, Real M, Will B, Kim E, Chou J, Alsaiari A, et al.
Transl Gastroenterol Hepatol
. 2023 May;
8:15.
PMID: 37197254
Background: Ampullary adenomas are lesions at the duodenum's major papilla commonly associated with familial adenomatous polyposis (FAP) but may also occur sporadically. Historically, ampullary adenomas were removed surgically, however endoscopic...
2.
Nakshabandi A, Rungta M, Othman M
Clin Liver Dis
. 2021 Nov;
26(1):13-19.
PMID: 34802659
Endoscopic mucosal resection and dissection are advanced endoscopic procedures that have proven essential for resecting premalignant and early malignant lesions throughout the gastrointestinal tract. Over time, these procedures have proven...
3.
Minhem M, Nakshabandi A, Mirza R, Alsamman M, Mattar M
World J Gastrointest Endosc
. 2021 Oct;
13(9):391-406.
PMID: 34630889
Background: Gastrointestinal hemorrhage (GIH) is a common complication with gastrointestinal cancers (GIC). There is no comprehensive research that examines GIH in different types of GIC. Aim: To study the prevalence,...
4.
Dao A, Hsu A, Nakshabandi A, Mandaliya R, Nadella S, Sivaraman A, et al.
World J Gastrointest Endosc
. 2019 Jun;
11(5):383-388.
PMID: 31205599
Background: Capecitabine is considered a first line agent in adjuvant therapy for breast and colorectal cancer. However, cases of severe diarrhea have been reported with increasing frequency in recent years....
5.
Jennings J, Mandaliya R, Nakshabandi A, Lewis J
Expert Opin Drug Metab Toxicol
. 2019 Jan;
15(3):231-244.
PMID: 30677306
Immune checkpoint inhibitors (ICIs) block cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1)/PD ligand 1 (PD-L1) receptors that control antitumor activities of lymphocytes. While highly...
6.
Anwar F, Abraham J, Nakshabandi A, Lee E
Int J Surg Case Rep
. 2018 Sep;
51:335-339.
PMID: 30245357
Introduction: Hungry bone syndrome (HBS) is rapid, intense and prolonged hypocalcemia that follows parathyroidectomy. The focus of this paper is HBS in patients with secondary hyperparathyroidism (SHPT) due to end...
7.
Alsina A, Athienitis A, Nakshabandi A, Claudio R, Aslam S, Arroyo J, et al.
Am J Surg
. 2018 May;
216(3):518-523.
PMID: 29803498
Background: Elective abdominal surgeries in patients with cirrhosis have been discouraged due to the high risk of complications. This study investigates the outcomes and safety of surgeries for hernias, and...
8.
Nakshabendi R, Berry A, Torres-Miranda D, LaBarbera F, Kanar O, Nakshabandi A, et al.
Case Rep Gastrointest Med
. 2016 Nov;
2016:7139573.
PMID: 27812393
In immunocompromised patients, histoplasmosis may present as disseminated disease. We present a 52-year-old Caucasian male with symptoms of dyspepsia, postprandial epigastric pain, nausea, and nonbloody diarrhea. Upper and lower gastrointestinal...
9.
Alsina A, Franco E, Nakshabandi A, Albers C, Kemmer N, Berry A, et al.
ACG Case Rep J
. 2016 Nov;
3(4):e106.
PMID: 27807568
Fibrolamellar hepatocellular carcinoma is a rare hepatocellular tumor usually arising in noninfected and noncirrhotic livers. Only 2 cases accompanied by hyperammonemia due to intrahepatic shunting have been reported. A 23-year-old...
10.
Nakshabendi R, Berry A, Nakshabandi A
Clin Gastroenterol Hepatol
. 2015 Mar;
13(10):e155-6.
PMID: 25724702
No abstract available.